OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00279059

AmorePacific Holdings Corp

Personal ProductsVerified

AmorePacific maintains a strong liquidity position with a current ratio of 2.51 and a cash and equivalents balance of 596.45 billion KRW, which supports its operational flexibility and short-term obligations. The company's debt-to-equity ratio is 0.1, indicating a conservative capital structure with limited leverage. Free cash flow of 347.78 billion KRW in the latest period reflects the company's ability to generate cash after capital expenditures. Profitability metrics show a return on equity of 3.56% and a return on assets of 1.41%, which are below the industry median for personal care products. This suggests that AmorePacific is underperforming in terms of asset and equity utilization compared to its peers. Operating income of 368.05 billion KRW and a gross profit of 3.4 trillion KRW indicate a solid gross margin, but the net income of 124.04 billion KRW suggests that operating expenses are consuming a significant portion of gross profit. The company's revenue is concentrated in a few key markets, with South Korea and China representing the largest geographic contributors. This concentration increases exposure to regional economic shifts and regulatory changes. AmorePacific's business is also segmented into cosmetics, skincare, and other personal care products, with cosmetics being the largest revenue driver. AmorePacific's growth trajectory is expected to remain stable, with revenue growth projected to be in line with the industry average. The company's capital expenditures of -106.95 billion KRW suggest a focus on cost optimization rather than expansion in the near term. Analysts have assigned a mean price target of 33,656.67 KRW, with a median of 34,000.00 KRW, indicating a generally positive outlook. The company's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. However, the low return on equity and return on assets suggest that the company may need to improve operational efficiency to enhance shareholder returns. No significant dilution sources were identified in recent filings, and the company's capital structure remains stable. Recent events include the release of the latest financial report, which showed a slight decline in net income compared to the previous year. The company has also been investing in digital transformation to enhance customer engagement and streamline operations.

30-day price · 002790-2050.00 (-7.4%)
Low$24850.00High$32150.00Close$25600.00As of15 May, 00:00 UTC
Profile
CompanyAmorePacific Holdings Corp
Ticker002790.KS
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. AmorePacific Holdings Corp is a South Korean personal care products company that generates revenue through the production and sale of cosmetics, skincare, and beauty products.

Classification. AmorePacific is classified under the Personal Products industry within the Personal & Household Products & Services business sector, with a classification confidence of 0.92.

AmorePacific maintains a strong liquidity position with a current ratio of 2.51 and a cash and equivalents balance of 596.45 billion KRW, which supports its operational flexibility and short-term obligations. The company's debt-to-equity ratio is 0.1, indicating a conservative capital structure with limited leverage. Free cash flow of 347.78 billion KRW in the latest period reflects the company's ability to generate cash after capital expenditures. Profitability metrics show a return on equity of 3.56% and a return on assets of 1.41%, which are below the industry median for personal care products. This suggests that AmorePacific is underperforming in terms of asset and equity utilization compared to its peers. Operating income of 368.05 billion KRW and a gross profit of 3.4 trillion KRW indicate a solid gross margin, but the net income of 124.04 billion KRW suggests that operating expenses are consuming a significant portion of gross profit. The company's revenue is concentrated in a few key markets, with South Korea and China representing the largest geographic contributors. This concentration increases exposure to regional economic shifts and regulatory changes. AmorePacific's business is also segmented into cosmetics, skincare, and other personal care products, with cosmetics being the largest revenue driver. AmorePacific's growth trajectory is expected to remain stable, with revenue growth projected to be in line with the industry average. The company's capital expenditures of -106.95 billion KRW suggest a focus on cost optimization rather than expansion in the near term. Analysts have assigned a mean price target of 33,656.67 KRW, with a median of 34,000.00 KRW, indicating a generally positive outlook. The company's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. However, the low return on equity and return on assets suggest that the company may need to improve operational efficiency to enhance shareholder returns. No significant dilution sources were identified in recent filings, and the company's capital structure remains stable. Recent events include the release of the latest financial report, which showed a slight decline in net income compared to the previous year. The company has also been investing in digital transformation to enhance customer engagement and streamline operations.
Key takeaways
  • AmorePacific has a conservative capital structure with a low debt-to-equity ratio and strong liquidity.
  • The company's profitability metrics are below the industry median, indicating room for improvement in asset and equity utilization.
  • Revenue is concentrated in key markets, increasing exposure to regional economic and regulatory risks.
  • Analysts have a generally positive outlook, with a mean price target of 33,656.67 KRW.
  • The company is focusing on cost optimization rather than expansion in the near term.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$4.62T
Gross profit$3.40T
Operating income$368.05B
Net income$124.04B
R&D
SG&A
D&A
SBC
Operating cash flow$629.67B
CapEx-$106.95B
Free cash flow$347.78B
Total assets$8.77T
Total liabilities$5.29T
Total equity$3.48T
Cash & equivalents$596.45B
Long-term debt$345.57B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$4.62T$368.05B$124.04B$347.78B
FY-1$4.26T$529.12B$252.03B$706.71B
FY-2$4.02T$111.22B$119.30B$190.17B
FY-3$4.49T$267.01B$62.24B$200.31B
FY-4$5.33T$294.08B$180.00B$493.53B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$8.77T$3.48T$596.45B
FY-1$8.54T$3.34T$558.02B
FY-2$7.63T$3.32T$616.11B
FY-3$7.65T$3.36T$637.82B
FY-4$8.04T$3.31T$870.36B
PeriodOCFCapExFCFSBC
FY0$629.67B-$106.95B$347.78B
FY-1$385.42B-$117.49B$706.71B
FY-2$389.47B-$231.60B$190.17B
FY-3$183.45B-$160.33B$200.31B
FY-4$762.59B-$131.11B$493.53B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$1.22T$56.24B
FQ-1$1.26T$54.76B$2.95B$59.40B
FQ-2$1.11T$104.26B$37.32B$110.45B
FQ-3$1.09T$80.12B$24.97B$84.96B
FQ-4$1.16T$128.86B$58.79B$176.31B
FQ-5$1.18T$79.03B-$6.34B$4.55B
FQ-6$1.07T$74.99B$26.42B$84.30B
FQ-7$1.01T$12.22B$190.04B$565.38B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$3.50T$765.15B
FQ-1$8.77T$3.48T$596.45B
FQ-2$8.54T$3.43T$528.87B
FQ-3$8.54T$3.38T$751.48B
FQ-4$8.63T$3.35T$725.44B
FQ-5$8.54T$3.34T$558.02B
FQ-6$8.48T$3.37T$536.02B
FQ-7$8.55T$3.33T$615.47B
PeriodOCFCapExFCFSBC
FQ0$161.74B-$32.13B
FQ-1$629.67B-$106.95B$59.40B
FQ-2$396.26B-$82.98B$110.45B
FQ-3$419.87B-$60.15B$84.96B
FQ-4$206.40B-$27.59B$176.31B
FQ-5$385.42B-$117.49B$4.55B
FQ-6$201.38B-$87.18B$84.30B
FQ-7$261.22B-$55.48B$565.38B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.48T
Net cash$250.88B
Current ratio2.5
Debt/Equity0.1
ROA1.4%
ROE3.6%
Cash conversion5.1%
CapEx/Revenue-2.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric002790Activity
Op margin8.0%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin2.7%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin73.6%60.1% medp25 60.1% · p75 60.1%top quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-2.3%-2.3% medp25 -4.4% · p75 -1.1%above median
Debt / equity10.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Observations
IR observations
Mean price target33,656.67 KRW
Median price target34,000.00 KRW
High price target45,000.00 KRW
Low price target21,970.00 KRW
Mean recommendation1.33 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate2,886.38 KRW
Last actual EPS1,361.00 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 00:04 UTCJob: 4b5a868d